BIOA Earnings Date: Nov 5, 2026 (Estimated) — BioAge Labs Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is BIOA's next earnings date?
BioAge Labs Inc. (BIOA) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.68 on revenue of $1.5M.
How did BIOA do in its last earnings report?
In its most recent report on Aug 6, 2026, BioAge Labs Inc. posted EPS of -$0.58 versus the -$0.61 estimate, a beat of 4.5%. Revenue was $2.5M against a $1.5M estimate. The stock's 1-day post-earnings move was +6.7%.
How much does BIOA stock move after earnings?
BIOA beat EPS estimates in 6 of its last 7 reported quarters. Over the last 8 reports the stock moved an average of 4.6% (up or down) in the day after earnings.
About BioAge Labs Inc.
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | -0.61 | -0.58 | +4.50% | $2.5M | ✅ Beat | +6.74% | -4.55% | -13.48% | |
| 2026-08-05 | Q2 2026 | -0.64 | -0.58 | +9.38% | $2.5M | ✅ Beat | +2.64% | -4.55% | -13.48% |
| 2026-05-08 | Q1 2026 | -0.64 | -0.52 | +18.75% | $2.8M | ✅ Beat | +0.95% | +5.02% | -12.96% |
| 2026-03-24 | Q4 2025 | -0.73 | -0.72 | +1.37% | $3.1M | ✅ Beat | -13.53% | -15.03% | -1.45% |
| 2025-11-06 | Q3 2025 | -0.58 | -0.56 | +3.45% | $2.1M | ✅ Beat | -2.81% | +3.35% | +58.37% |
| 2025-08-06 | Q2 2025 | -0.45 | -0.60 | -33.33% | $2.4M | ❌ Miss | -0.23% | +5.31% | +9.72% |
| 2025-03-20 | Q4 2024 | -0.83 | -0.59 | +28.92% | $0 | ✅ Beat | +2.51% | -11.42% | -8.22% |
| 2024-11-07 | Q3 2024 | — | -6.70 | — | $0 | — | +7.61% | -5.38% | -77.45% |
Showing last 8 quarters.